These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Characterization in Rodent Seizure and Epilepsy Models. Leclercq K; Matagne A; Provins L; Klitgaard H; Kaminski RM J Pharmacol Exp Ther; 2020 Jan; 372(1):11-20. PubMed ID: 31619464 [TBL] [Abstract][Full Text] [Related]
10. Metabolism, pharmacokinetics, and anticonvulsant activity of a deuterated analog of the α2/3-selective GABAkine KRM-II-81. Golani LK; Divović B; Sharmin D; Pandey KP; Mian MY; Cerne R; Zahn NM; Meyer MJ; Tiruveedhula VVNPB; Smith JL; Ping X; Jin X; Lippa A; Schkeryantz JM; Arnold LA; Cook JM; Savić MM; Witkin JM Biopharm Drug Dispos; 2022 Apr; 43(2):66-75. PubMed ID: 35194800 [TBL] [Abstract][Full Text] [Related]
11. Comparative anticonvulsant activity of the GABAkine KRM-II-81 and a deuterated analog. Ping X; Meyer MJ; Zahn NM; Golani LK; Sharmin D; Pandey KP; Revanian S; Mondal P; Jin X; Arnold LA; Cerne R; Cook JM; Divović B; Savić MM; Lippa A; Smith JL; Witkin JM Drug Dev Res; 2023 May; 84(3):527-531. PubMed ID: 36748904 [TBL] [Abstract][Full Text] [Related]
12. The value of human epileptic tissue in the characterization and development of novel antiepileptic drugs: The example of CERC-611 and KRM-II-81. Witkin JM; Ping X; Cerne R; Mouser C; Jin X; Hobbs J; Tiruveedhula VVNPB; Li G; Jahan R; Rashid F; Kumar Golani L; Cook JM; Smith JL Brain Res; 2019 Nov; 1722():146356. PubMed ID: 31369732 [TBL] [Abstract][Full Text] [Related]
17. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy. Löscher W; Lehmann H; Behl B; Seemann D; Teschendorf HJ; Hofmann HP; Lubisch W; Höger T; Lemaire HG; Gross G Eur J Neurosci; 1999 Jan; 11(1):250-62. PubMed ID: 9987029 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects of KRM-II-81, positive allosteric modulator for α2/3 subunit containing GABA Nakakubo S; Hiramatsu Y; Goto T; Kimura S; Narugami M; Nakajima M; Ueda Y; Shiraishi H; Manabe A; Sharmin D; Cook JM; Egawa K Front Pharmacol; 2023; 14():1273633. PubMed ID: 37849734 [No Abstract] [Full Text] [Related]
19. Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor. Carter RB; Wood PL; Wieland S; Hawkinson JE; Belelli D; Lambert JJ; White HS; Wolf HH; Mirsadeghi S; Tahir SH; Bolger MB; Lan NC; Gee KW J Pharmacol Exp Ther; 1997 Mar; 280(3):1284-95. PubMed ID: 9067315 [TBL] [Abstract][Full Text] [Related]
20. Influence of hippocampal low-frequency stimulation on GABA Xu K; Liu Z; Wang L; Wu G; Liu T Brain Res; 2018 Nov; 1698():195-203. PubMed ID: 30118718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]